Antisense gene therapy trials underway in patients with CML.
D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006801:Humans; D007262:Infusions, Intravenous; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008875:Middle Aged; D009838:Oligodeoxyribonucleotides; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*
C104404:LR 3001; D009838:Oligodeoxyribonucleotides; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense